Opening Bell: Futures, Global Stocks Drop On New Vaccine Delays; Oil Rebounds

 | Oct 13, 2020 12:30

  • J&J's coronavirus vaccine study halted due to unexplained illness
  • NASDAQ notched best day since April on Monday
  • US banks start reporting results today, kicking off Q3 earnings season
  • Key Events/h2

    Johnson & Johnson's (NYSE:JNJ) announcement yesterday that it was pausing its trial on a COVID-19 vaccine sent US futures, including for the Dow, S&P, and Russell 2000, as well as European shares into the red on Tuesday. However, NASDAQ futures bucked the trend ahead of Apple's expected announcement of a 5G enabled iPhone after the US markets open later today.

    The dollar jumped with yields, weighing on gold. Oil recovered but is caught in the crossfire of conflicting themes.

    Global Financial Affairs/h2

    Contracts on the S&P 500 fell 0.5%, at the time of writing, after the news from JNJ that its trial has been halted because of an unexplained illness in a participant. However, traders may take the view that such speed bumps are par for the course as vaccine trials progress after last month’s similar hiatus by AstraZeneca (NYSE:AZN), which proved temporary.

    Stimulus in the US is looking less likely once again after members of the House were told not to expect action this week as the confirmation hearings for the next Supreme Court judge started on Monday. As well, many Senate Republicans had already rejected the newest proposal from President Trump, indicating the plan was announce the addition of 5G to its new iPhone on Tuesday, saw its share price target increased by RBC Capital Markets to $390 from $345. Twitter (NYSE:TWTR) rallied when Deutsche Bank (NYSE:DB) increased its price target on the stock from $36 to $56.

    Yields, including for the 10-year Treasury note, dropped to 0.75, but remained above the 200 DMA, which has been a proven support for the fourth straight day.